ENTITY
Keymed Biosciences

Keymed Biosciences (2162 HK)

67
Analysis
Health CareHong Kong
Keymed Biosciences Inc. operates a biotechnology company. The Company focus on the in-house discovery and development of innovative biological therapies. Keymed Biosciences provides services in China.
more
04 Jul 2021 10:21

ECM Weekly (4th July 2021) - Xpeng, Medbot, Medlive, Brii Bio, CTOS, LinkDoc, Devyani, Manycore

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
bearish3SBio Inc
29 Jun 2021 09:09

3SBio Inc (1530.HK) - The Concerns and the Outlook

This insight mainly analyzed the potential reasons behind the decline in 3SBio Group's share price, the important products, the pipeline, the...

Logo
253 Views
Share
bullishDiDi Global
27 Jun 2021 11:39

ECM Weekly (27th June 2021) - Didi, Xpeng, Zylox, Dingdong, EBeauty, Chaoju Eye Care, Keymed Bio

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
25 Jun 2021 14:40

Keymed (康诺亚生物) IPO: A Free Option for Overseas Potential

Keymed's IPO valuation only reflects the value derived from China market. The value derived from the overseas market will be the free option for...

Logo
525 Views
Share
08 Jun 2021 14:34

Keymed (康诺亚生物) Pre-IPO: Differentiated Products but Far from Commercialization

We highlight that Keymed is led by experienced management team with strong R&D track record which is evidenced by its differentiated product pipeline.

Logo
364 Views
Share
x